tiprankstipranks
Trending News
More News >
AXIM Biotechnologies Inc (AXIM)
OTHER OTC:AXIM
US Market

AXIM Biotechnologies (AXIM) Income Statement

Compare
151 Followers

AXIM Biotechnologies Income Statement

Last quarter (Q2 2025), AXIM Biotechnologies's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q2, AXIM Biotechnologies's net income was $135.92K. See AXIM Biotechnologies’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 70.46K$ 39.52K$ 8.88K$ 60.46K$ 0.00
Gross Profit
$ -369.27K$ 39.52K$ -417.25K$ 60.46K$ -16.00K
Operating Expenses
$ 1.39M$ 2.79M$ 4.66M$ 7.79M$ 4.83M
Depreciation and Amortization
$ 432.39K$ 427.02K$ 426.13K$ 2.12M$ 16.00K
EBITDA
$ -2.44M$ -6.43M$ -3.94M$ -13.17M$ -4.93M
Operating Income
$ -1.76M$ -2.75M$ -4.65M$ -7.99M$ -4.95M
Other Income/Expenses
$ -1.75M$ -5.31M$ -1.59M$ -2.05M$ -1.34M
Pretax Income
$ -3.51M$ -8.06M$ -6.24M$ -16.02M$ -6.29M
Net Income
$ -3.51M$ -8.06M$ -5.96M$ -16.52M$ -6.73M
Per Share Metrics
Basic EPS
$ -0.01$ -0.04$ -0.04$ -0.13$ -0.06
Diluted EPS
$ -0.01$ -0.04$ -0.04$ -0.13$ -0.06
Weighted Average Shares Outstanding
318.90M 227.69M 165.47M 131.54M 110.39M
Weighted Average Shares Outstanding (Diluted)
318.90M 227.69M 165.47M 131.54M 110.39M
Currency in USD

AXIM Biotechnologies Earnings and Revenue History